CHERIE HOWARD: Open Payments
NPI 1003534355 · KINSTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,530 in 74 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,530
Food & beverage: $1,530
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $293 |
| Vanda Pharmaceuticals Inc. | 15 | $256 |
| Otsuka America Pharmaceutical, Inc. | 9 | $196 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $175 |
| Luye Pharma (USA) Ltd. | 3 | $150 |
| Neurocrine BioSciences, Inc. | 6 | $116 |
| E.R. Squibb & Sons, L.L.C. | 5 | $109 |
| Teva Pharmaceuticals USA, Inc. | 4 | $58 |
| Lundbeck LLC | 2 | $50 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
Products named: VRAYLAR, HETLIOZ, REXULTI, CAPLYTA, ERZOFRI EXTENDED-RELEASE, INGREZZA, COBENFY, ABILIFY ASIMTUFII.
Industry payments across NC — which companies pay providers there.
